Search results
Results from the WOW.Com Content Network
Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL
Free Malaysia Today (FMT) is an independent, bilingual news online portal with content, in both English and Bahasa Malaysia (Malay), with a focus on Malaysian current affairs, published since 2009. [ 1 ] [ 2 ] It is one of Malaysia 's most accessed news sites with monthly visits of 11.83 million.
Malaysiakini was founded by Premesh Chandran and Steven Gan in November 1999. [5] [6] Frustrated with the constraints they experienced while working for The Sun newspaper, Premesh and Gan decided to use the Multimedia Super Corridor (MSC) pledge to create a space for uncensored journalism.
Construction of the complex in May 2019. The mall was built through a partnership and collaboration deal between Australian-based developer Lendlease (Lendlease Development Malaysia Sdn Bhd) and the main developer of the district (TRX City Sdn Bhd), in which the former had owned 60% of the development and the remaining by the latter of which is a subsidiary wholly owned by the Finance Ministry ...
BRUSSELS (Reuters) -Teva, the world's largest generic drugmaker, will be hit with an EU antitrust fine in the coming weeks for disparaging a rival product to its blockbuster multiple sclerosis ...
The generic drug maker Teva Pharmaceuticals agreed Monday to pay $225 million to settle price-fixing charges related to sales of a major cholesterol-lowering drug. The U.S. Department of Justice ...
The Borneo Post, established in 1978, is the largest and widely circulated English-language daily newspaper in East Malaysia and also the alternately circulated newspaper in Brunei (as a strong competitor to the main existing newspapers of Pelita Brunei, Borneo Bulletin and also Media Permata, to a lesser extent, the now-defunct Brunei Times). [3]
Teva Pharmaceuticals sued rival drugmaker Corcept Therapeutics in federal court in San Francisco on Thursday, accusing it of monopolizing the market for mifepristone-based Korlym, used to treat a ...